The difference, of course, is significant. “Joseph Keating, main investment strategist at First American Asset Management, lately pointed out within an article that the SPX’s price-to-earnings (P/E) proportion dropped to 17 as of the third quarter of 2006 – most affordable since mid-1995. Meanwhile, the SPX has gone 221 days without a two-percent correction now.

John Salerno, Chairman of iGambit, “We are extremely honored and pleased to have someone of Robert Randelman’s caliber join our Senior Advisory Board. About iGambit Inc.: iGambit (OTCBB: IGMB) is a fully confirming publicly-held company. We are a company focused on seeking specific medical strategies and objectives. These objectives have included, among others, the acquisition of medical technology companies with strong growth potential regarded in the public area easily. We believe that the back-ground of our management, our Board of Directors, and our Advisory Board in the medical and technology markets are a valuable resource which makes us a desirable business partner.

We expect to work to assume an active role in the development and development of the new company, providing both tactical guidance and functional support. The management of iGambit is convinced it can leverage its collective knowledge to help position the combined company to produce high-margin, predictable, and recurring income and create long-term value for our stockholders.

  • Indoor residual spraying
  • U. S. Treasury bills may be used to approximate the risk-free rate
  • Savings and looking at accounts
  • 6 years back from Parsippany, New Jersey

Information on our web-site will not comprise a part of this press release. SMITHTOWN, NY, May 8, 2017 Marketwire — iGambit Inc. (OTCQB: IGMB), announced that Dr. Benedict S. Maniscalco has joined its Senior Advisory Board. This comes after the acquisition of HubCentrix and the CyberCare Health Network Chronic Care Management System. The goal of HealthDatix is to identify the patient’s eligibility for Medicare reimbursed doctor appointments to access and assist in the well-being and cultivation of a wholesome lifestyle. Additionally HealthDatix will be able to offer an FDA approved, Medicare covered system, for constant management of persistent care patients.

Our continuous care platform will be tailored for individual treatment and health management of patients susceptible to chronic illness. This includes CyberCare’s wearable medical watch. Dr. Benedict S. Maniscalco, M.D. From 1976 through early 1979 Dr. Maniscalco was on the faculty of the University of South Florida School of Medicine, department of Cardiology in Tampa, Florida. In 1979 Later, Dr. Maniscalco was recruiting to determine the cardiac catheterization laboratory at St. Joseph’s hospital in Tampa.

He subsequently expanded the program and founded the nationally acknowledged St. Joseph’s Heart Institute which offered as a model for cardiovascular programs throughout the united states. Dr. Maniscalco served as Chief of Cardiology and Director of the cardiac catheterization lab until from its founding through 2001. In this particular capacity, many of the innovative procedures and technology of modern cardiovascular services were implemented.

While Director of the Heart Institute, Dr. Maniscalco was an officer and director of a big multi-specialty cardiovascular group practice. Over his distinguished career, Dr. Maniscalco has offered as an advisor, opinion loudspeaker, and innovator for numerous companies in both pharmaceutical and device industry. He has lectured throughout the national country for both medical and industry co-workers. He has been involved and led many research efforts in both clinical and non-clinical areas of investigation. Dr. Maniscalco has been a person in and served many healthcare societies. In the American College of Cardiology, he served in many capacities at the neighborhood, state, and national levels.

He has made significant efforts on numerous committees and in many capacities including his tenure as President and Governor of the Florida Chapter of the American College of Cardiology. His specific contributions in the areas of health policy and socioeconomic issues were numerous. Today, Dr. Maniscalco proceeds his devotion to patients in an avoidance and consultative cardiology practice in Tampa, Florida and on an international basis as CEO and Chairman of Heartbeat International Foundation (HBI)! HBI provides pacemakers, defibrillators, and other cardiac services to the less fortunate in developing countries of the global world.

Over 15,000 patients’ lives have been kept or changed by the efforts of Heartbeat International and the countless volunteer doctors and co-workers worldwide. John Salerno, Chairman of iGambit, “We are very very happy to have Dr. Maniscalco join us in our new business opportunity. About iGambit Inc: iGambit (OTCBB: IGMB) is a fully reporting publicly-held company. We are a company focused on going after specific medical strategies and goals. These goals have included, among others, the acquisition of medical technology companies with strong growth potential easily identified in the public arena.

We believe that the back-ground of our management and of our Board of Directors in the technology marketplaces is a very important resource that makes us a desirable business partner. We expect to work to assume an active role in the development and development of the new company, providing both proper guidance and functional support.